GENOMIC TESTING COOPERATIVE, LCA

Genomic Testing Cooperative, LCA specializes in advanced molecular diagnostics for hematologic and oncologic conditions, delivering next-generation sequencing services to identify somatic gene mutations in bone marrow and blood samples. Their core capabilities center on high-plex targeted NGS panels, including 177-gene hematologic profiling, to support precision diagnosis and treatment guidance for complex blood disorders. The contractor leverages clinical-grade laboratory workflows to detect low-frequency variants, enabling actionable insights for clinicians managing myeloid malignancies and other hematologic diseases. Technical expertise includes bioinformatics pipeline development, variant annotation, and regulatory-compliant data reporting aligned with clinical decision-making frameworks. Their specialization in somatic mutation analysis for bone marrow specimens distinguishes them as a niche provider in translational genomics for federal research and clinical programs. The contractor maintains a consistent and deep relationship with the Department of Health and Human Services, delivering genomic testing services primarily through NIH institutes, particularly the National Heart, Lung, and Blood Institute. Their work supports investigator-driven research and clinical trial support, focusing on molecular characterization of hematologic diseases and therapeutic response monitoring. Operating under NAICS 621511 for medical laboratories and 621991 for blood and organ banks, the company is positioned at the intersection of clinical diagnostics and biomedical research, serving the growing demand for genomic biomarker discovery in hematologic oncology. Their market positioning reflects a focus on high-complexity, research-to-clinical translation services rather than broad-based clinical lab testing. Genomic Testing Cooperative, LCA is a small, privately held entity based in Lake Forest, California, with no federal certifications on record. Their geographic footprint is concentrated in California, with operations tailored to serve federal research and public health agencies requiring specialized genomic diagnostics.